Good morning!

Judges Scientific (LON:JDG)

Share price: 1297p
No. shares: 6.0m
Market Cap: £77.8m

These shares had been recovering from the shock profit warning in Jul 2014, but today they have lurched down again by 240p (15%) to 1297p this morning - roughly the previous low in July. So results must have disappointed, let's take a look.

Interim results - for the six months to 30 Jun 2014 are out today. The group's strategy is to grow through repeated acquisitions, buying private companies cheaply. This is kept rolling by having highly rated shares, thus the acquisitions are earnings enhancing, and only a relatively small number of shares need to be issued from time to time because the cashflow from the acquired companies, combined with a modest amount of bank debt, has funded most of the acquisitions. It's a clever business model, and has been executed brilliantly by CEO, David Cicurel.

The rating got far too high in the 2013/early 2014 bull market, and these shares have now almost halved since the peak.

The interim figures look OK to me, so I'm a little perplexed as to why the share price has dropped so sharply today. Adjusted EPS came in at 50.3p for the half year, up 22%. Although the growth seems to have all come from an acquisition, with no organic growth.

Outlook - the order book seems to be the reason investors are concerned;

Organic order intake during the six-month period decreased 4.8% compared to the first half of 2013; total order intake (including Scientifica) was 11% below the level required to meet the Group's sales budget without consuming its order book. The second quarter showed a moderate but insufficient improvement compared to the first. The order book at 30 June 2014 represented 7.8 weeks of sales, compared to 10.6 weeks at 30 June 2013.

Trading at the start of the second half has continued to be difficult. Weekly order intake in the third quarter has broadly mirrored the activity seen in the first half.

Broker forecasts - WH Ireland has trimmed its full year EPS forecast from 86.4p to 80.3p, but given that the group achieved 50.3p in H1, that seems a fairly pessimistic view for H2 (of only about 30p EPS). I suppose if you assume that is the new level of earnings, at about 30p EPS per half year, then that suggests a drop to only…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here